Skip to content

Royalty Pharma Sub-Manager, LLC

Follow

13F filer, CIK 2081668, New York, NY

Royalty Pharma Sub-Manager, LLC reported $196,268,588 across 4 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13.

Accepted , ingested 13F-HR 0002081668-26-000021

Period
2026-09-30
Reported value
$196M
Holdings
4
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0002081668-26-000021, largest first. % of portfolio is the value over $196,268,588, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 980,392 shares; 2026Q1: 980,392 shares; 2026Q2: 980,392 shares; 2026Q3: 980,392 shares 980,392$64.6M32.92%0Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,263,150 shares; 2026Q1: 2,388,150 shares; 2026Q2: 2,388,150 shares; 2026Q3: 2,388,150 shares 2,388,150$64.4M32.82%0Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 2,936,507 shares; 2026Q1: 2,936,507 shares; 2026Q2: 2,936,507 shares; 2026Q3: 2,936,507 shares 2,936,507$39.2M19.97%0Timeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,455,357 shares; 2026Q3: 2,455,357 shares 2,455,357$28M14.29%0Timeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002081668-26-000021 base2026-11-13